A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults
Phase of Trial: Phase IV
Latest Information Update: 09 Jan 2018
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors MedImmune
- 03 Jan 2018 Status changed from active, no longer recruiting to completed.
- 20 Sep 2017 Planned End Date changed from 22 Dec 2017 to 21 Dec 2017.
- 20 Sep 2017 Planned primary completion date changed from 22 Dec 2017 to 21 Dec 2017.